Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mitsuya

Showing results (261-270 of 343) with videos related to

Pageof 35
Sort By:
Antimicrobial Agents and Chemotherapy|February 1, 1990
Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitroS Hayashi, D W Norbeck, W Rosenbrook, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1993
Anomalous accumulation and decay of 2',3'-dideoxyadenosine-5'-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2',3'-dideoxyinosineG Ahluwalia, D A Cooney, N R Hartman, et al.
The Journal of Experimental Medicine|July 1, 1985
Human T cell leukemia/lymphoma virus I infection and subsequent cloning of normal human B cells. Direct responsiveness of cloned cells to recombinant interleukin 2 by differentiation in the absence of enhanced proliferationS Tomita, J L Ambrus, D J Volkman, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2001
4'-Ethynyl nucleoside analogs: potent inhibitors of multidrug-resistant human immunodeficiency virus variants in vitroE I Kodama, S Kohgo, K Kitano, et al.
Biochemical Pharmacology|September 1, 1987
2',3'-Dideoxy-2'-fluoro-ara-A. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV)V E Marquez, C K Tseng, J A Kelley, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1995
Pharmacokinetics of dideoxypurine nucleoside analogs in plasma and cerebrospinal fluid of rhesus monkeysM E Hawkins, H Mitsuya, C M McCully, et al.
Journal of Medicinal Chemistry|January 11, 1991
A ring-enlarged oxetanocin A analogue as an inhibitor of HIV infectivityC K Tseng, V E Marquez, G W Milne, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1990
Lipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitroT Shirasaka, K Murakami, H Ford, et al.
The Journal of Biological Chemistry|June 2, 2000
Differential influence of nucleoside analog-resistance mutations K65R and L74V on the overall mutation rate and error specificity of human immunodeficiency virus type 1 reverse transcriptaseF S Shah, K A Curr, M E Hamburgh, et al.
Biochemical Pharmacology|July 1, 1986
Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivityD A Cooney, M Dalal, H Mitsuya, et al.
Pageof 35

Showing results (261-270 of 343) with videos related to

Sort By:
Pageof 35
Antimicrobial Agents and Chemotherapy|February 1, 1990
Cyclobut-A and cyclobut-G, carbocyclic oxetanocin analogs that inhibit the replication of human immunodeficiency virus in T cells and monocytes and macrophages in vitroS Hayashi, D W Norbeck, W Rosenbrook, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 1, 1993
Anomalous accumulation and decay of 2',3'-dideoxyadenosine-5'-triphosphate in human T-cell cultures exposed to the anti-HIV drug 2',3'-dideoxyinosineG Ahluwalia, D A Cooney, N R Hartman, et al.
The Journal of Experimental Medicine|July 1, 1985
Human T cell leukemia/lymphoma virus I infection and subsequent cloning of normal human B cells. Direct responsiveness of cloned cells to recombinant interleukin 2 by differentiation in the absence of enhanced proliferationS Tomita, J L Ambrus, D J Volkman, et al.
Antimicrobial Agents and Chemotherapy|April 17, 2001
4'-Ethynyl nucleoside analogs: potent inhibitors of multidrug-resistant human immunodeficiency virus variants in vitroE I Kodama, S Kohgo, K Kitano, et al.
Biochemical Pharmacology|September 1, 1987
2',3'-Dideoxy-2'-fluoro-ara-A. An acid-stable purine nucleoside active against human immunodeficiency virus (HIV)V E Marquez, C K Tseng, J A Kelley, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1995
Pharmacokinetics of dideoxypurine nucleoside analogs in plasma and cerebrospinal fluid of rhesus monkeysM E Hawkins, H Mitsuya, C M McCully, et al.
Journal of Medicinal Chemistry|January 11, 1991
A ring-enlarged oxetanocin A analogue as an inhibitor of HIV infectivityC K Tseng, V E Marquez, G W Milne, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 1, 1990
Lipophilic halogenated congeners of 2',3'-dideoxypurine nucleosides active against human immunodeficiency virus in vitroT Shirasaka, K Murakami, H Ford, et al.
The Journal of Biological Chemistry|June 2, 2000
Differential influence of nucleoside analog-resistance mutations K65R and L74V on the overall mutation rate and error specificity of human immunodeficiency virus type 1 reverse transcriptaseF S Shah, K A Curr, M E Hamburgh, et al.
Biochemical Pharmacology|July 1, 1986
Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivityD A Cooney, M Dalal, H Mitsuya, et al.
Pageof 35